IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis.

Int J Mol Sci · 2022 · PMC8745093 · PMID 35008981

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significantp = 0.051so close (0.05 < p ≤ 0.1)

However, we observed borderline significant higher IL-17C levels in patients with CVD when PASI ≤ 10 (3.27 vs. 2.82, p = 0.051, Figure 5 , lower right). 3.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.